- Publication : 23 12 2010
- Catégorie : La recherche médicale et génétique
Randomized, double-blind, placebo-controlled trial of hydroxyurea in spinal muscular atrophy.
The purpose of this study was to evaluate the safety and efficacy of hydroxyurea (HU) in spinal muscular atrophy (SMA) in a randomized, double-blind, placebo-controlled trial.
Source : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?tmpl=NoSidebarfile&db=PubMed&cmd=Retrieve&list_uids=21172842&dopt=Abstract
Partager